REFERENCES
- L. V. AllenJr., N. G. Popovich, and H. C. Ansel. (2005). Ansel's pharmaceutical dosage forms and drug delivery systems (8th ed., pp. 265–266Lippincott Williams & Wilkins.
- P. Barthelemya, J. P. Laforeˆta, N. Faraha, and J. Joachimb. (1999). Compritol ® 888 ATO: An innovative hot-melt coating agent for prolonged-release drug formulations. Eur. J. Pharm. Biopharm. 47:87–90.
- L. D. Bruce, J. J. Koleng, and J. W. McGinity. (2003). The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Drug Dev. Ind. Pharm. 29:909–924.
- L. D. Bruce, H. J. Petereit, T. Beckert, and J. W. McGinty. (2003). Properties of enteric coated sodium valproate pellets. Int. J. Pharm. 264:85–96.
- G. Crotts, A. Sheth, J. Twist, and I. Ghebre-Sellassie. (2001). Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble organic acid. Eur. J. Pharm. Biopharm. 51:71–76.
- L. A. Felton, M. M. Haase, N. H. Shah, G. Zhang, M. H. Infeld, A. W. Malick, and et al (1995). Physical and enteric properties of soft gelatin capsules coated with Eudragit L30D-55. Int. J. Pharm. 113:17–24.
- G. Frenning, Å. Tunón, and G. Alderborn. (2003). Modelling of drug release from coated granular pellets. J. Control. Release 92:113–123.
- A. M. Garcia, and E. S. Ghaly. (1996). Preliminary spherical agglomerates of water soluble drug using natural polymer and cross-linking technique. J. Control. Release 40:179–186.
- H. X. Guo, J. Heinamaki, and J. Yliruusi. (2002). Amylopectin as a subcoating material improves the acidic resistance of enteric-coated pellets containing a freely soluble drug. Int. J. Pharm. 235:79–86.
- J. Hamdani, A. J. Moe¨s, and K. Amighi. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int. J. Pharm. 245:167–177.
- P. W. S. Heng, J. Hao, L. W. Chan, and S. H. Chew. (2007). Influences of osmotic agents in diffusion layer on drug release from multilayer coated pellets. Drug Dev. Ind. Pharm. 30:213–220.
- K. Lehmann. (1997). Chemistry and application properties of polymethacrylate coating systems. In J. W. McGinity. Aqueous polymeric coatings for pharmaceutical dosage forms (2nd ed., pp. 101–176). New York, Basel, Hong Kong: Marcel Dekker, Inc..
- S. P. Li, and K. M. Feld. (1997). The effect of polymer coating systems on the preparation, tableting, and dissolution properties of sustained-release drug pellets. Drug Dev. Ind. Pharm. 23:623–631.
- J. W. Matthews, G. Vergilio. (1989). Process for coating gelatin capsules, US Patent Issued on March, 28.
- A. G. Ozturk, S. S. Ozturk, B. O. Palsson, T. A. Wheatley, and J. B. Dressman. (1990). Mechanism of release from pellets coated with an ethylcellulose-based film. J. Control. Release 14:203–213.
- T. Phaechamud, and G. C. Ritthidej. (2007). Sustained-release from layered matrix system comprising chitosan and xanthan gum. Drug Dev. Ind. Pharm. 33:595–605.
- F. Sadeghi, J. L. Ford, M. H. Rubinstein, and A. R. Rajabi-Siahboomi. (2000). Comparative study of drug release from pellets coated with HPMC or surelease. Drug Dev. Ind. Pharm. 26:651–660.
- N. Sinchaipanid, V. Junyaprasert, and A. Mitrevej. (2004). Application of hot-melt coating for controlled release of propranolol hydrochloride pellets. Powder Tech. 141:203–209.
- K. Umprayn, P. Chitropas, and S. Amarekajorn. (1999). Development of terbutaline sulfate sustained-release coated pellets. Drug Dev. Ind. Pharm. 25:477–491.
- H.-X. Zeng, G. Cheng, W. -S. Pan, G.-P. Zhong, and M. Huang. (2007). Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs. Drug Dev. Ind. Pharm. 33:649–665.
- W. J. Zheng, and W. James. (2003). Influence of Eudragit® NE30D blended with Eudragit L30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev. Ind. Pharm. 29:357–366.